Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim for CIT in NSCLC
NCT00413283Phase 2Completed
- Sponsor
- Amgen
- Start
- Dec 2006
- Primary completion
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 2 trial of romiplostim in chemotherapy-induced thrombocytopenia (CIT), sponsored by Amgen. Started Dec 2006; status: completed.
02
Drugs
romiplostim
03
Conditions
chemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on NCT00413283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413283.